Comparison of prothrombin time tests used in the monitoring of edoxaban and their evaluation as indicators of the reversal effect View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-03-16

AUTHORS

Toshiaki Iba, Mari Emmi, Makoto Hiki, Masataka Nagayama, Koichiro Aihara, Yoko Tabe, Maiko Yuri, Akimichi Ohsaka

ABSTRACT

Clinical demand for the prompt assessment of the activity of direct-acting factor Xa inhibitors in the emergency care setting is increasing. In the present study, we examined whether prothrombin time (PT) tests can serve as a clinically useful indicator of anti-factor Xa activity. In the first series, the in vitro effect of edoxaban on PT was evaluated by spiking human plasma with edoxaban and measuring PT using three different commercial PT tests. In the second series, the reversal effect of prothrombin complex concentrates (PCC) and activated PCC (aPCC) in edoxaban-spiked plasma was evaluated. In the third series, PT of plasma samples from patients administered either 15 or 30 mg/day of edoxaban was assessed, and the results were compared with edoxaban concentrations determined by a calibrated anti-factor Xa activity assay. The spike test revealed that all PT reagents positively correlated with edoxaban. The sensitivity to edoxaban varied among the three reagents and Triniclot® Excel S showed the best performance. Prolonged PT by edoxaban was reversed by PCC and aPCC in a dose-dependent manner; however, complete reversal was not achieved. Positive correlation between anti-factor Xa activity and PT was shown in the clinical samples at the edoxaban range from 0 to >300 ng/mL. More... »

PAGES

665-672

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12185-016-1975-5

DOI

http://dx.doi.org/10.1007/s12185-016-1975-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013360176

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26984594


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Coagulation Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Factor Xa Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prothrombin Time", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazoles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258269.2", 
          "name": [
            "Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iba", 
        "givenName": "Toshiaki", 
        "id": "sg:person.01070237056.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070237056.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Scientific and Technical Support Department, Kyowa Medex Co., Ltd., Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.473316.4", 
          "name": [
            "Scientific and Technical Support Department, Kyowa Medex Co., Ltd., Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Emmi", 
        "givenName": "Mari", 
        "id": "sg:person.0652621217.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652621217.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258269.2", 
          "name": [
            "Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hiki", 
        "givenName": "Makoto", 
        "id": "sg:person.0647646475.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647646475.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Orthopaedics, Juntendo University School of Medicine, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258269.2", 
          "name": [
            "Department of Orthopaedics, Juntendo University School of Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagayama", 
        "givenName": "Masataka", 
        "id": "sg:person.01236274526.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236274526.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258269.2", 
          "name": [
            "Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aihara", 
        "givenName": "Koichiro", 
        "id": "sg:person.01313252615.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313252615.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Laboratory Medicine, Juntendo University School Medicine, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258269.2", 
          "name": [
            "Department of Clinical Laboratory Medicine, Juntendo University School Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tabe", 
        "givenName": "Yoko", 
        "id": "sg:person.01130154025.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130154025.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411966.d", 
          "name": [
            "Division of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yuri", 
        "givenName": "Maiko", 
        "id": "sg:person.01323404556.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323404556.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411966.d", 
          "name": [
            "Division of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohsaka", 
        "givenName": "Akimichi", 
        "id": "sg:person.0602506713.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602506713.39"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11239-011-0591-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000154375", 
          "https://doi.org/10.1007/s11239-011-0591-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-015-1185-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022047665", 
          "https://doi.org/10.1007/s11239-015-1185-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40261-014-0229-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040460172", 
          "https://doi.org/10.1007/s40261-014-0229-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-011-0622-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019297634", 
          "https://doi.org/10.1007/s11239-011-0622-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-03-16", 
    "datePublishedReg": "2016-03-16", 
    "description": "Clinical demand for the prompt assessment of the activity of direct-acting factor Xa inhibitors in the emergency care setting is increasing. In the present study, we examined whether prothrombin time (PT) tests can serve as a clinically useful indicator of anti-factor Xa activity. In the first series, the in vitro effect of edoxaban on PT was evaluated by spiking human plasma with edoxaban and measuring PT using three different commercial PT tests. In the second series, the reversal effect of prothrombin complex concentrates (PCC) and activated PCC (aPCC) in edoxaban-spiked plasma was evaluated. In the third series, PT of plasma samples from patients administered either 15 or 30\u00a0mg/day of edoxaban was assessed, and the results were compared with edoxaban concentrations determined by a calibrated anti-factor Xa activity assay. The spike test revealed that all PT reagents positively correlated with edoxaban. The sensitivity to edoxaban varied among the three reagents and Triniclot\u00ae Excel S showed the best performance. Prolonged PT by edoxaban was reversed by PCC and aPCC in a dose-dependent manner; however, complete reversal was not achieved. Positive correlation between anti-factor Xa activity and PT was shown in the clinical samples at the edoxaban range from 0 to\u00a0>300\u00a0ng/mL.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12185-016-1975-5", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5874124", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1076985", 
        "issn": [
          "0925-5710", 
          "1865-3774"
        ], 
        "name": "International Journal of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "103"
      }
    ], 
    "keywords": [
      "anti-factor Xa activity", 
      "prothrombin complex concentrate", 
      "Xa activity", 
      "prothrombin time test", 
      "day of edoxaban", 
      "emergency care settings", 
      "effects of edoxaban", 
      "dose-dependent manner", 
      "factor Xa inhibitors", 
      "reversal effect", 
      "edoxaban concentration", 
      "care settings", 
      "edoxaban", 
      "complex concentrate", 
      "Xa inhibitors", 
      "time test", 
      "prompt assessment", 
      "plasma samples", 
      "PT test", 
      "clinical samples", 
      "complete reversal", 
      "present study", 
      "clinical demand", 
      "PT reagents", 
      "positive correlation", 
      "human plasma", 
      "second series", 
      "useful indicator", 
      "first series", 
      "third series", 
      "patients", 
      "activity", 
      "aPCC", 
      "test", 
      "plasma", 
      "effect", 
      "inhibitors", 
      "days", 
      "setting", 
      "indicators", 
      "assessment", 
      "samples", 
      "study", 
      "evaluation", 
      "series", 
      "sensitivity", 
      "reversal", 
      "correlation", 
      "manner", 
      "concentration", 
      "monitoring", 
      "concentrate", 
      "comparison", 
      "results", 
      "reagents", 
      "Pt", 
      "range", 
      "spike test", 
      "demand", 
      "performance", 
      "better performance", 
      "different commercial PT tests", 
      "commercial PT tests", 
      "edoxaban-spiked plasma", 
      "calibrated anti-factor Xa activity", 
      "Triniclot", 
      "Excel S", 
      "edoxaban range", 
      "monitoring of edoxaban"
    ], 
    "name": "Comparison of prothrombin time tests used in the monitoring of edoxaban and their evaluation as indicators of the reversal effect", 
    "pagination": "665-672", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013360176"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12185-016-1975-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26984594"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12185-016-1975-5", 
      "https://app.dimensions.ai/details/publication/pub.1013360176"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_700.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12185-016-1975-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-1975-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-1975-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-1975-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-1975-5'


 

This table displays all metadata directly associated to this object as RDF triples.

240 TRIPLES      22 PREDICATES      107 URIs      95 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12185-016-1975-5 schema:about N10ad85f6db584147ad092af99da9337f
2 N17253090c08948ad9a498609c0743c0d
3 N70849072b32642d2917917b786f15200
4 N90d431381d7e434e80f47ca52c8b33bf
5 Nbd7c981b69ea471cb9edc2ffd1d2662c
6 Nc3cad221e1c44fa79eddbcf20867613f
7 Nda01739d679e40c7b0200e26aeefbd52
8 Ne057ed277cbe4750a8241b4c4b777bd6
9 anzsrc-for:11
10 anzsrc-for:1103
11 schema:author Nbca176fb172a467db8fe5e3ca739517f
12 schema:citation sg:pub.10.1007/s11239-011-0591-8
13 sg:pub.10.1007/s11239-011-0622-5
14 sg:pub.10.1007/s11239-015-1185-7
15 sg:pub.10.1007/s40261-014-0229-7
16 schema:datePublished 2016-03-16
17 schema:datePublishedReg 2016-03-16
18 schema:description Clinical demand for the prompt assessment of the activity of direct-acting factor Xa inhibitors in the emergency care setting is increasing. In the present study, we examined whether prothrombin time (PT) tests can serve as a clinically useful indicator of anti-factor Xa activity. In the first series, the in vitro effect of edoxaban on PT was evaluated by spiking human plasma with edoxaban and measuring PT using three different commercial PT tests. In the second series, the reversal effect of prothrombin complex concentrates (PCC) and activated PCC (aPCC) in edoxaban-spiked plasma was evaluated. In the third series, PT of plasma samples from patients administered either 15 or 30 mg/day of edoxaban was assessed, and the results were compared with edoxaban concentrations determined by a calibrated anti-factor Xa activity assay. The spike test revealed that all PT reagents positively correlated with edoxaban. The sensitivity to edoxaban varied among the three reagents and Triniclot® Excel S showed the best performance. Prolonged PT by edoxaban was reversed by PCC and aPCC in a dose-dependent manner; however, complete reversal was not achieved. Positive correlation between anti-factor Xa activity and PT was shown in the clinical samples at the edoxaban range from 0 to >300 ng/mL.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N9c1e4fdd7e3c4d5ba38308a7bbaec31e
23 Nc06807be65ca4f3794cd8dc165bbe110
24 sg:journal.1076985
25 schema:keywords Excel S
26 PT reagents
27 PT test
28 Pt
29 Triniclot
30 Xa activity
31 Xa inhibitors
32 aPCC
33 activity
34 anti-factor Xa activity
35 assessment
36 better performance
37 calibrated anti-factor Xa activity
38 care settings
39 clinical demand
40 clinical samples
41 commercial PT tests
42 comparison
43 complete reversal
44 complex concentrate
45 concentrate
46 concentration
47 correlation
48 day of edoxaban
49 days
50 demand
51 different commercial PT tests
52 dose-dependent manner
53 edoxaban
54 edoxaban concentration
55 edoxaban range
56 edoxaban-spiked plasma
57 effect
58 effects of edoxaban
59 emergency care settings
60 evaluation
61 factor Xa inhibitors
62 first series
63 human plasma
64 indicators
65 inhibitors
66 manner
67 monitoring
68 monitoring of edoxaban
69 patients
70 performance
71 plasma
72 plasma samples
73 positive correlation
74 present study
75 prompt assessment
76 prothrombin complex concentrate
77 prothrombin time test
78 range
79 reagents
80 results
81 reversal
82 reversal effect
83 samples
84 second series
85 sensitivity
86 series
87 setting
88 spike test
89 study
90 test
91 third series
92 time test
93 useful indicator
94 schema:name Comparison of prothrombin time tests used in the monitoring of edoxaban and their evaluation as indicators of the reversal effect
95 schema:pagination 665-672
96 schema:productId N4eadf01eb7244af0b0c2ad66edb25fd9
97 Nc469c0a5640841c6ad44fc9ca4543b7a
98 Nf677857f747b4e96a8b9bac3244cd113
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013360176
100 https://doi.org/10.1007/s12185-016-1975-5
101 schema:sdDatePublished 2022-01-01T18:40
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher Na4604058b7db42c29455e0bd16d9e24e
104 schema:url https://doi.org/10.1007/s12185-016-1975-5
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N02c9c7a8218d4fc1bd7857250d24b78f rdf:first sg:person.01236274526.07
109 rdf:rest N2261d1a963a540c282aad285cb6c4ea4
110 N10ad85f6db584147ad092af99da9337f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Humans
112 rdf:type schema:DefinedTerm
113 N17253090c08948ad9a498609c0743c0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Thiazoles
115 rdf:type schema:DefinedTerm
116 N2261d1a963a540c282aad285cb6c4ea4 rdf:first sg:person.01313252615.47
117 rdf:rest N412986a08e9f415dabe898cf350b15c8
118 N412986a08e9f415dabe898cf350b15c8 rdf:first sg:person.01130154025.08
119 rdf:rest Nc76c54b4b74c42d6ad4d8bd39666e1bc
120 N4eadf01eb7244af0b0c2ad66edb25fd9 schema:name pubmed_id
121 schema:value 26984594
122 rdf:type schema:PropertyValue
123 N70849072b32642d2917917b786f15200 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Blood Coagulation Factors
125 rdf:type schema:DefinedTerm
126 N76af80ac665c4daf99b5d21c57d8b3ac rdf:first sg:person.0602506713.39
127 rdf:rest rdf:nil
128 N7fa6fc64e4774eada870fe65ce3997c1 rdf:first sg:person.0647646475.17
129 rdf:rest N02c9c7a8218d4fc1bd7857250d24b78f
130 N90d431381d7e434e80f47ca52c8b33bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Prothrombin Time
132 rdf:type schema:DefinedTerm
133 N9c1e4fdd7e3c4d5ba38308a7bbaec31e schema:issueNumber 6
134 rdf:type schema:PublicationIssue
135 Na4604058b7db42c29455e0bd16d9e24e schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 Nbca176fb172a467db8fe5e3ca739517f rdf:first sg:person.01070237056.38
138 rdf:rest Nfe8274fdb3d2433983b703ba30b5bdf7
139 Nbd7c981b69ea471cb9edc2ffd1d2662c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Factor Xa Inhibitors
141 rdf:type schema:DefinedTerm
142 Nc06807be65ca4f3794cd8dc165bbe110 schema:volumeNumber 103
143 rdf:type schema:PublicationVolume
144 Nc3cad221e1c44fa79eddbcf20867613f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Drug Monitoring
146 rdf:type schema:DefinedTerm
147 Nc469c0a5640841c6ad44fc9ca4543b7a schema:name dimensions_id
148 schema:value pub.1013360176
149 rdf:type schema:PropertyValue
150 Nc76c54b4b74c42d6ad4d8bd39666e1bc rdf:first sg:person.01323404556.91
151 rdf:rest N76af80ac665c4daf99b5d21c57d8b3ac
152 Nda01739d679e40c7b0200e26aeefbd52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Dose-Response Relationship, Drug
154 rdf:type schema:DefinedTerm
155 Ne057ed277cbe4750a8241b4c4b777bd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Pyridines
157 rdf:type schema:DefinedTerm
158 Nf677857f747b4e96a8b9bac3244cd113 schema:name doi
159 schema:value 10.1007/s12185-016-1975-5
160 rdf:type schema:PropertyValue
161 Nfe8274fdb3d2433983b703ba30b5bdf7 rdf:first sg:person.0652621217.83
162 rdf:rest N7fa6fc64e4774eada870fe65ce3997c1
163 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
164 schema:name Medical and Health Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
167 schema:name Clinical Sciences
168 rdf:type schema:DefinedTerm
169 sg:grant.5874124 http://pending.schema.org/fundedItem sg:pub.10.1007/s12185-016-1975-5
170 rdf:type schema:MonetaryGrant
171 sg:journal.1076985 schema:issn 0925-5710
172 1865-3774
173 schema:name International Journal of Hematology
174 schema:publisher Springer Nature
175 rdf:type schema:Periodical
176 sg:person.01070237056.38 schema:affiliation grid-institutes:grid.258269.2
177 schema:familyName Iba
178 schema:givenName Toshiaki
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070237056.38
180 rdf:type schema:Person
181 sg:person.01130154025.08 schema:affiliation grid-institutes:grid.258269.2
182 schema:familyName Tabe
183 schema:givenName Yoko
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130154025.08
185 rdf:type schema:Person
186 sg:person.01236274526.07 schema:affiliation grid-institutes:grid.258269.2
187 schema:familyName Nagayama
188 schema:givenName Masataka
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236274526.07
190 rdf:type schema:Person
191 sg:person.01313252615.47 schema:affiliation grid-institutes:grid.258269.2
192 schema:familyName Aihara
193 schema:givenName Koichiro
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313252615.47
195 rdf:type schema:Person
196 sg:person.01323404556.91 schema:affiliation grid-institutes:grid.411966.d
197 schema:familyName Yuri
198 schema:givenName Maiko
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323404556.91
200 rdf:type schema:Person
201 sg:person.0602506713.39 schema:affiliation grid-institutes:grid.411966.d
202 schema:familyName Ohsaka
203 schema:givenName Akimichi
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602506713.39
205 rdf:type schema:Person
206 sg:person.0647646475.17 schema:affiliation grid-institutes:grid.258269.2
207 schema:familyName Hiki
208 schema:givenName Makoto
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647646475.17
210 rdf:type schema:Person
211 sg:person.0652621217.83 schema:affiliation grid-institutes:grid.473316.4
212 schema:familyName Emmi
213 schema:givenName Mari
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652621217.83
215 rdf:type schema:Person
216 sg:pub.10.1007/s11239-011-0591-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000154375
217 https://doi.org/10.1007/s11239-011-0591-8
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/s11239-011-0622-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019297634
220 https://doi.org/10.1007/s11239-011-0622-5
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s11239-015-1185-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022047665
223 https://doi.org/10.1007/s11239-015-1185-7
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s40261-014-0229-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040460172
226 https://doi.org/10.1007/s40261-014-0229-7
227 rdf:type schema:CreativeWork
228 grid-institutes:grid.258269.2 schema:alternateName Department of Clinical Laboratory Medicine, Juntendo University School Medicine, Tokyo, Japan
229 Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan
230 Department of Orthopaedics, Juntendo University School of Medicine, Tokyo, Japan
231 schema:name Department of Clinical Laboratory Medicine, Juntendo University School Medicine, Tokyo, Japan
232 Department of Emergency and Disaster Medicine, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, 113-8421, Tokyo, Japan
233 Department of Orthopaedics, Juntendo University School of Medicine, Tokyo, Japan
234 rdf:type schema:Organization
235 grid-institutes:grid.411966.d schema:alternateName Division of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan
236 schema:name Division of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan
237 rdf:type schema:Organization
238 grid-institutes:grid.473316.4 schema:alternateName Scientific and Technical Support Department, Kyowa Medex Co., Ltd., Tokyo, Japan
239 schema:name Scientific and Technical Support Department, Kyowa Medex Co., Ltd., Tokyo, Japan
240 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...